Risk mitigating behaviours in people with inflammatory joint and skin disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey
SK Mahil, M Yates, SM Langan, ZZN Yiu, T Tsakok, N Dand, KJ Mason, H McAteer, F Meynell, B Coker, A Vincent, D Urmston, A Vesty, J Kelly, C Lancelot, L Moorhead, H Bachelez, IN Bruce, F Capon, CR Contreras, AP Cope, C De La Cruz, P Di Meglio, P Gisondi, K Hyrich, D Jullien, J Lambert, H Waweru, H Marzo-Ortega, I McKinnes, L Naldi, S Norton, L Puig, R Sengupta, P Spuls, T Torres, RB Warren, J Weinman, CM Griffiths, JN Barker, MA Brown, JB Galloway, CH Smith On behalf of the PsoProtect and CORE-UK study groups
doi: https://doi.org/10.1101/2020.11.05.20226662
SK Mahil
1St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK
M Yates
2Centre for Rheumatic Diseases, King’s College London, London, UK
SM Langan
1St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK
3Faculty of Epidemiology, and Population Health, London School of Hygiene and Tropical Medicine, London, UK
ZZN Yiu
4Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK
T Tsakok
1St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK
N Dand
5Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King’s College London, London, UK
6Health Data Research UK, London, UK
KJ Mason
4Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK
7School of Medicine, Keele University, Keele, UK
H McAteer
8The Psoriasis Association, Northampton, UK
F Meynell
1St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK
B Coker
9NIHR Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK
A Vincent
9NIHR Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK
D Urmston
8The Psoriasis Association, Northampton, UK
A Vesty
8The Psoriasis Association, Northampton, UK
J Kelly
4Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK
C Lancelot
10International Federation of Psoriasis Associations
L Moorhead
1St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK
H Bachelez
11Department of Dermatology, AP-HP Hôpital Saint-Louis, Paris, France
12INSERM U1163, Imagine Institute for Human Genetic Diseases, Université de Paris, Paris, France
IN Bruce
13Kellegren Centre for Rheumatology, NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
14Versus Arthritis Centre for Genetics and Genomics, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK
F Capon
5Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King’s College London, London, UK
9NIHR Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK
CR Contreras
15Catedra de Dermatologia, Hospital de Clinicas, Facultad de Ciencias Medicas, Universidad Nacional de Asuncion, Paraguay
AP Cope
2Centre for Rheumatic Diseases, King’s College London, London, UK
C De La Cruz
16Clinica Dermacross, Santiago, Chile
P Di Meglio
9NIHR Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK
17St John’s Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King’s College London, London, UK
P Gisondi
18Section of Dermatology and Venereology, University of Verona, Verona, Italy
K Hyrich
13Kellegren Centre for Rheumatology, NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
14Versus Arthritis Centre for Genetics and Genomics, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK
D Jullien
19Department of Dermatology, Edouard Herriot Hospital, Hospices Civils de Lyon, University of Lyon, Lyon, France
20Groupe de recherche sur le psoriasis (GrPso) de la Société française de dermatologie, Paris, France
J Lambert
21Department of Dermatology, Ghent University, Ghent, Belgium
H Waweru
15Catedra de Dermatologia, Hospital de Clinicas, Facultad de Ciencias Medicas, Universidad Nacional de Asuncion, Paraguay
H Marzo-Ortega
22NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, UK
23Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK
I McKinnes
24Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow UK
L Naldi
25Centro Studi GISED, Bergamo, Italy
S Norton
26Psychology Department, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
L Puig
27Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain
R Sengupta
28Royal United Hospitals Bath NHS Trust, Bath, UK
P Spuls
29Department of Dermatology, Amsterdam Public Health/Infection and Immunology, Amsterdam University Medical Centers, Location AMC, Amsterdam, The Netherlands
T Torres
30Department of Dermatology, Centro Hospitalar do Porto, Portugal
RB Warren
4Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK
J Weinman
31School of Cancer and Pharmaceutical Sciences, King’s College London, London, UK
CM Griffiths
4Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK
JN Barker
9NIHR Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK
17St John’s Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King’s College London, London, UK
MA Brown
2Centre for Rheumatic Diseases, King’s College London, London, UK
9NIHR Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK
JB Galloway
2Centre for Rheumatic Diseases, King’s College London, London, UK
CH Smith
1St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK
9NIHR Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK
Data Availability
Summary level data available on reasonable request.
Posted November 07, 2020.
Risk mitigating behaviours in people with inflammatory joint and skin disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey
SK Mahil, M Yates, SM Langan, ZZN Yiu, T Tsakok, N Dand, KJ Mason, H McAteer, F Meynell, B Coker, A Vincent, D Urmston, A Vesty, J Kelly, C Lancelot, L Moorhead, H Bachelez, IN Bruce, F Capon, CR Contreras, AP Cope, C De La Cruz, P Di Meglio, P Gisondi, K Hyrich, D Jullien, J Lambert, H Waweru, H Marzo-Ortega, I McKinnes, L Naldi, S Norton, L Puig, R Sengupta, P Spuls, T Torres, RB Warren, J Weinman, CM Griffiths, JN Barker, MA Brown, JB Galloway, CH Smith
medRxiv 2020.11.05.20226662; doi: https://doi.org/10.1101/2020.11.05.20226662
Risk mitigating behaviours in people with inflammatory joint and skin disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey
SK Mahil, M Yates, SM Langan, ZZN Yiu, T Tsakok, N Dand, KJ Mason, H McAteer, F Meynell, B Coker, A Vincent, D Urmston, A Vesty, J Kelly, C Lancelot, L Moorhead, H Bachelez, IN Bruce, F Capon, CR Contreras, AP Cope, C De La Cruz, P Di Meglio, P Gisondi, K Hyrich, D Jullien, J Lambert, H Waweru, H Marzo-Ortega, I McKinnes, L Naldi, S Norton, L Puig, R Sengupta, P Spuls, T Torres, RB Warren, J Weinman, CM Griffiths, JN Barker, MA Brown, JB Galloway, CH Smith
medRxiv 2020.11.05.20226662; doi: https://doi.org/10.1101/2020.11.05.20226662
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (676)
- Anesthesia (182)
- Cardiovascular Medicine (2676)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12304)
- Forensic Medicine (10)
- Gastroenterology (768)
- Genetic and Genomic Medicine (4149)
- Geriatric Medicine (389)
- Health Economics (684)
- Health Informatics (2688)
- Health Policy (1009)
- Hematology (365)
- HIV/AIDS (859)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (444)
- Neurology (3931)
- Nursing (212)
- Nutrition (584)
- Oncology (2068)
- Ophthalmology (592)
- Orthopedics (243)
- Otolaryngology (307)
- Pain Medicine (252)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1128)
- Primary Care Research (461)
- Public and Global Health (6572)
- Radiology and Imaging (1418)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (54)
- Transplantation (189)
- Urology (169)